BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Essand M. Virotherapy of neuroendocrine tumors. Neuroendocrinology 2013;97:26-34. [PMID: 22378183 DOI: 10.1159/000336084] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Ma J, Jin C, Čančer M, Wang H, Ramachandran M, Yu D. Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus. Mol Ther Oncolytics 2021;21:356-66. [PMID: 34141872 DOI: 10.1016/j.omto.2021.04.016] [Reference Citation Analysis]
2 Kloker LD, Berchtold S, Smirnow I, Beil J, Krieg A, Sipos B, Lauer UM. Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms. BMC Cancer 2020;20:628. [PMID: 32631270 DOI: 10.1186/s12885-020-07121-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chen S, Zhang Q, Xu D, Li Y, Fan Y, Li W, Yin X, Zhang Y, Liu J, Li X, Sun L, Jin N. Antitumor effect of the Newcastle disease viral hemagglutinin-neuraminidase gene is expressed through an oncolytic adenovirus effect in osteosarcoma cells. Anticancer Drugs 2018;29:197-207. [PMID: 29438228 DOI: 10.1097/CAD.0000000000000575] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Walenkamp A, Crespo G, Fierro Maya F, Fossmark R, Igaz P, Rinke A, Tamagno G, Vitale G, Öberg K, Meyer T. Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment. Endocr Relat Cancer 2014;21:R445-60. [PMID: 25296914 DOI: 10.1530/ERC-14-0106] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
5 Jin C, Yu D, Čančer M, Nilsson B, Leja J, Essand M. Tat-PTD-modified oncolytic adenovirus driven by the SCG3 promoter and ASH1 enhancer for neuroblastoma therapy. Hum Gene Ther 2013;24:766-75. [PMID: 23889332 DOI: 10.1089/hum.2012.132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
6 Veenstra MJ, de Herder WW, Feelders RA, Hofland LJ. Targeting the somatostatin receptor in pituitary and neuroendocrine tumors. Expert Opinion on Therapeutic Targets 2013;17:1329-43. [DOI: 10.1517/14728222.2013.830711] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
7 Ramachandran M, Yu D, Wanders A, Essand M, Eriksson F. An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors. Mol Ther. 2013;21:2008-2018. [PMID: 23817216 DOI: 10.1038/mt.2013.153] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]